Two portfolio companies finalists in the inaugural 2020 Nature Spinoff Prize
We’re proud to announce that Caristo Diagnostics Ltd and Oxford Brain Diagnostics Ltd, have both been shortlisted for the inaugural 2020 Nature Spinoff Prize.
The prize represents a partnership between Nature Research, a scientific publishing firm, and Merck & Co., a pharmaceutical company, celebrating excellence in the commercialisation of research through the creation of university spinout companies globally.
The shortlist includes 12 spinout companies from 150 candidates chosen from around the world, with one-third of shortlisted candidates originating from UK academic institutions, and one-sixth from Oxford University. The final live pitch event is to be held on 13th July 2020 and the winner will be awarded the title of 2020 Nature Spin-off Prize champion, as well as a grant of €30,000. We wish both companies the best of luck.